Lexicon Pharmaceuticals
LXRX
#7142
Rank
A$0.76 B
Marketcap
A$2.11
Share price
-1.41%
Change (1 day)
109.15%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.12 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.24 B22.51%
2023-12-31A$0.20 B76.43%
2022-12-31A$0.11 B252.66%
2021-12-31A$32.15 M-47.85%
2020-12-31A$61.66 M-85.64%
2019-12-31A$0.42 B-2.6%
2018-12-31A$0.44 B-6.55%
2017-12-31A$0.47 B6.85%
2016-12-31A$0.44 B-12.16%
2015-12-31A$0.50 B119.52%
2014-12-31A$0.22 B96.36%
2013-12-31A$0.11 B15.28%
2012-12-31A$0.10 B-22%
2011-12-31A$0.12 B9.88%
2010-12-31A$0.11 B12.45%
2009-12-31A$0.10 B12.72%
2008-12-31A$93.09 M-1.61%
2007-12-31A$94.62 M-28.8%
2006-12-31A$0.13 B-26.84%
2005-12-31A$0.18 B55.52%
2004-12-31A$0.11 B-26.42%
2003-12-31A$0.15 B180.6%
2002-12-31A$56.56 M33.54%
2001-12-31A$42.35 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
A$3.91 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$13.86 B 10,640.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$1.76 B 1,269.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.34 B 1,716.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$78.08 B 60,372.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.22 B 850.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$5.71 B 4,325.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.79 B 513.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$0.81 B 529.11%๐Ÿ‡บ๐Ÿ‡ธ USA